• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

byCheng En Xi
September 10, 2026
in Endocrinology, Ophthalmology
Reading Time: 2 mins read
Share on FacebookShare on Twitter

1. Nguyen and colleagues developed and evaluated a deep-learning model for detecting diabetic macular edema using 3D OCT scans.

2. The model achieved accuracy, sensitivity, and specificity above 90% in a real-world screening program and flagged uncertain cases for specialist review.

Evidence Rating Level: 2 (Good)

Study Rundown: Diabetic macular edema (DME) is the primary cause of vision loss among individuals with diabetes, and early detection of DME is crucial for preventing and delaying visual impairment. Nguyen and colleagues developed a privacy-preserving deep-learning model to detect DME and distinguish center-involved DME (CI-DME) from non-CI-DME using 3D OCT scans. The model was trained through federated learning on multicenter data without transferring patient images between institutions. The model was then prospectively evaluated in a diabetic retinopathy screening program in Vietnam. The main performance metrics were accuracy, sensitivity, specificity, and comparisons with ophthalmologists. The study found that the model achieved an accuracy of 93.70%, a sensitivity of 91.78%, and a specificity of 93.06%. Diagnostic performance was lower for distinguishing CI-DME from non-CI-DME. The model also identified 64 uncertain cases for ophthalmologist review and performed similarly to human experts. This study demonstrated that a deep-learning model can be used to expand DME screening in lower-resourced settings.

Click here to read the study in NEJM AI

Relevant Reading: Real-world performance of an AI system for diabetic retinopathy screening

RELATED REPORTS

Artificial intelligence based clinical exam training significantly improved medical students’ standardized clinical exam performance

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

In-Depth [prospective cohort]: The model was developed and evaluated using 8,031 OCT volumes from 1,958 adults across five centers in Hong Kong, Singapore, and the United States. Three Hong Kong datasets were used for federated training, while Singaporean and American datasets were used for external retrospective testing. The model first detected DME and then classified positive scans as CI-DME or non-CI-DME. Federated averaging enabled collaborative training without sharing patient images. For prospective testing, 1,473 OCT volumes from 753 consecutively recruited participants in a Vietnamese diabetic retinopathy screening program were analyzed in real time. OCT scans were classified as positive, negative, or uncertain; uncertain cases were referred to ophthalmologists. Performance metrics included area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, and specificity. The model achieved 93.70% accuracy (95% confidence interval [CI], 91.24-94.01%), 91.78% sensitivity (95% CI, 86.84-94.36%), and 93.06% specificity (95% CI, 91.53-94.49%) for DME detection. CI-DME classification achieved 83.75% accuracy (95% CI, 78.17-88.83%), 85.61% sensitivity (95% CI, 79.56-91.17%), and 79.31% specificity (95% CI, 68.75-89.09%). A total of 64 cases were identified as uncertain and were referred to ophthalmologists. This study was limited by the use of a single commercial OCT device, imperfect specificity that could increase referrals, and uncertainty regarding the optimal management of borderline cases. Overall, this study demonstrated that DME can be effectively screened using a deep-learning model to expand access in lower-resourced settings.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: artificial intelligencedeep learningdiabetesdiabetic macular edema
Previous Post

FDA-cleared AI devices rarely have patient outcome data

RelatedReports

Artificial Intelligence

Artificial intelligence based clinical exam training significantly improved medical students’ standardized clinical exam performance

September 9, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

September 3, 2026
Cost-related medication nonadherence associated with increased ED utilization
Pharma

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

September 4, 2026
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
  • Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.